These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 22652624)
1. microRNA biomarkers in body fluids of prostate cancer patients. Kuner R; Brase JC; Sültmann H; Wuttig D Methods; 2013 Jan; 59(1):132-7. PubMed ID: 22652624 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer. Martens-Uzunova ES; Jalava SE; Dits NF; van Leenders GJ; Møller S; Trapman J; Bangma CH; Litman T; Visakorpi T; Jenster G Oncogene; 2012 Feb; 31(8):978-91. PubMed ID: 21765474 [TBL] [Abstract][Full Text] [Related]
3. A panel of five circulating microRNAs as potential biomarkers for prostate cancer. Chen ZH; Zhang GL; Li HR; Luo JD; Li ZX; Chen GM; Yang J Prostate; 2012 Sep; 72(13):1443-52. PubMed ID: 22298030 [TBL] [Abstract][Full Text] [Related]
4. [MicroRNAs and prostate cancer]. Yang CH; Zhang CN Zhonghua Nan Ke Xue; 2010 Sep; 16(9):844-9. PubMed ID: 21171273 [TBL] [Abstract][Full Text] [Related]
5. MicroRNAs in prostate cancer: from biomarkers to molecularly-based therapeutics. Gordanpour A; Nam RK; Sugar L; Seth A Prostate Cancer Prostatic Dis; 2012 Dec; 15(4):314-9. PubMed ID: 22333688 [TBL] [Abstract][Full Text] [Related]
6. A review of expression profiling of circulating microRNAs in men with prostate cancer. Kelly BD; Miller N; Healy NA; Walsh K; Kerin MJ BJU Int; 2013 Jan; 111(1):17-21. PubMed ID: 22612403 [TBL] [Abstract][Full Text] [Related]
7. miRNAs as molecular biomarkers of cancer. Fabbri M Expert Rev Mol Diagn; 2010 May; 10(4):435-44. PubMed ID: 20465498 [TBL] [Abstract][Full Text] [Related]
10. A model for data analysis of microRNA expression in forensic body fluid identification. Wang Z; Luo H; Pan X; Liao M; Hou Y Forensic Sci Int Genet; 2012 May; 6(3):419-23. PubMed ID: 21903498 [TBL] [Abstract][Full Text] [Related]
11. MicroRNAs in breast cancer pathogenesis. Götte M Minerva Ginecol; 2010 Dec; 62(6):559-71. PubMed ID: 21079577 [TBL] [Abstract][Full Text] [Related]
12. Role of miRNA in carcinogenesis and biomarker selection: a methodological view. Ahmed FE Expert Rev Mol Diagn; 2007 Sep; 7(5):569-603. PubMed ID: 17892365 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic review. Endzeliņš E; Melne V; Kalniņa Z; Lietuvietis V; Riekstiņa U; Llorente A; Linē A Mol Cancer; 2016 May; 15(1):41. PubMed ID: 27189160 [TBL] [Abstract][Full Text] [Related]
14. Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review). Allegra A; Alonci A; Campo S; Penna G; Petrungaro A; Gerace D; Musolino C Int J Oncol; 2012 Dec; 41(6):1897-912. PubMed ID: 23026890 [TBL] [Abstract][Full Text] [Related]
15. Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers. Zen K; Zhang CY Med Res Rev; 2012 Mar; 32(2):326-48. PubMed ID: 22383180 [TBL] [Abstract][Full Text] [Related]
16. miRNAs can predict prostate cancer biochemical relapse and are involved in tumor progression. Fendler A; Jung M; Stephan C; Honey RJ; Stewart RJ; Pace KT; Erbersdobler A; Samaan S; Jung K; Yousef GM Int J Oncol; 2011 Nov; 39(5):1183-92. PubMed ID: 21769427 [TBL] [Abstract][Full Text] [Related]